M
Maedeh Sorkhi
Researcher at Tehran University of Medical Sciences
Publications - 11
Citations - 287
Maedeh Sorkhi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Antibacterial activity & Circular dichroism. The author has an hindex of 9, co-authored 11 publications receiving 250 citations. Previous affiliations of Maedeh Sorkhi include University of Tehran.
Papers
More filters
Journal ArticleDOI
Chromene-based synthetic chalcones as potent antileishmanial agents: synthesis and biological activity.
Alireza Foroumadi,Saeed Emami,Maedeh Sorkhi,Maryam Nakhjiri,Zohreh Nazarian,Samaneh Heydari,Sussan K. Ardestani,Fatemeh Poorrajab,Abbas Shafiee +8 more
TL;DR: Results from in vitro biological assays indicated that chloro‐substituted 1‐(6‐methoxy‐2H‐chromen‐3‐yl)‐3-phenylpropen‐1‐ones exhibited excellent activity against Leishmania major at non‐cytotoxic concentrations.
Journal ArticleDOI
Synthesis and antioxidant properties of substituted 3-benzylidene-7-alkoxychroman-4-ones.
Alireza Foroumadi,Alireza Samzadeh-Kermani,Saeed Emami,Gholamreza Dehghan,Maedeh Sorkhi,Fatemeh Arabsorkhi,M R Heidari,Mohammad Abdollahi,Abbas Shafiee +8 more
TL;DR: 3-Benzylidene-7-alkoxychroman-4-one derivatives bearing catecholic group on benzylidenes moiety exhibited excellent antioxidant activity and were more active than the reference drug, Trolox.
Journal ArticleDOI
Synthesis, Analgesic and Anti-Inflammatory Activity of 4-(2-Phenoxyphenyl)semicarbazones
Ardeshir Rineh,Nosratollah Mahmoodi,Mohammad Abdollahi,Alireza Foroumadi,Maedeh Sorkhi,Abbas Shafiee +5 more
TL;DR: A series of 4‐(2‐phenoxyphenyl)semicarbazones was synthesized and evaluated for their analgesic and anti‐inflammatory activities and, based on the results of an anti-inflammatory study, 1‐(1‐ (2,5‐dimethoxyphensyl)ethylidene)‐4‐( 2‐phen oxyphenol)seicarbazide 11i was the most active compound.
Journal ArticleDOI
5‐Nitroimidazole‐based 1,3,4‐Thiadiazoles: Heterocyclic Analogs of Metronidazole as Anti‐Helicobacter pylori Agents
Mohammad Hassan Moshafi,Maedeh Sorkhi,Saeed Emami,Maryam Nakhjiri,Azadeh Yahya-Meymandi,Amir Soheil Negahbani,Farideh Siavoshi,Maryam Omrani,Eskandar Alipour,Mohsen Vosooghi,Abbas Shafiee,Alireza Foroumadi +11 more
TL;DR: Compound 6f containing the 3,5‐dimethylpiperazinyl moiety at the 2‐position of the 5‐(1‐methyl‐5‐nitro‐1H‐imidazol‐2‐yl)‐1,3,4‐thiadiazole skeleton was the most potent compound tested at low concentrations.
Journal ArticleDOI
Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids.
Alireza Foroumadi,Shahla Mansouri,Saeed Emami,Javad Mirzaei,Maedeh Sorkhi,Nosratollah Saeid-Adeli,Abbas Shafiee +6 more
TL;DR: Novel levofloxacin‐containing hybrids carrying a 5‐(nitroaryl)‐1,3,4‐thiadiazol‐2‐yl group were synthesized and evaluated in vitro against Gram‐positive and Gram‐negative bacteria.